Featured Research

from universities, journals, and other organizations

Certain genetic profiles associated with recurrence-free survival for non-small cell lung cancer

Date:
February 11, 2010
Source:
JAMA and Archives Journals
Summary:
An analysis of genetic and clinical data for nearly 800 patients with non-small cell lung cancer has identified differences in genetic characteristics that are associated with age and sex specific patterns of increased or decreased recurrence-free survival, according to a new study.

An analysis of genetic and clinical data for nearly 800 patients with non-small cell lung cancer has identified differences in genetic characteristics that are associated with age and sex specific patterns of increased or decreased recurrence-free survival, according to a study in the February 10 issue of JAMA.

Related Articles


The five-year overall survival rate for lung cancer is only 15 percent, and it remains the leading cause of cancer-related death in the United States. An estimated 159,000 lung cancer deaths occurred in 2009, and more than 219,000 new cases were diagnosed. Almost half of these new cases are diagnosed in women, with approximately 30 percent to 40 percent of cases diagnosed in patients older than 70 years, with the majority of these cases (greater than 85 percent) non-small cell lung cancer (NSCLC), according to background information in the article.

"Despite evidence that clinical and pathologic factors (e.g., age, histology, smoking status, sex) are clinically relevant, little is known regarding the underlying biological differences in lung tumor gene expression among patients with different clinicopathologic characteristics. A deeper understanding of molecular abnormalities at a pathway level [involving gene expression and biochemical reactions that transmit information within and between cells] may help dissect the complex mechanisms of lung cancer oncogenesis [development of tumors], shed light on the biological underpinnings contributing to survival differences in NSCLC that are age- and sex-based, and further help identify specific cohorts of patients that may be more susceptible to novel individualized therapeutic strategies," the authors write.

William Mostertz, M.S., of Duke University, Durham, N.C., and colleagues examined clinically relevant differences in the underlying biology of NSCLC based on patient age and sex. The study consisted of an analysis, performed from July 2008 to June 2009, of 787 patients with predominantly early stage NSCLC. Lung tumor samples with corresponding microarray (genetic analysis of biological material) and clinical data were used. All patients were divided into subgroups based on age (less than 70 vs. 70 years or older) or sex.

Low- and high-risk patient clusters/groups were identified with the longest and shortest 5-year recurrence-free survival, respectively, within the age and sex NSCLC subgroups. The researchers found that these cohorts of NSCLC demonstrated unique patterns of pathway activation. In patients younger than 70 years, high-risk patients, with the shortest recurrence-free survival, demonstrated increased activation of the Src (a gene) (25 percent vs. 6 percent) and tumor necrosis (death of cells or tissue) factor (76 percent vs. 42 percent) pathways compared with low-risk patients. High-risk patients ages 70 years or older demonstrated increased activation of the wound healing (40 percent vs. 24 percent) and invasiveness (64 percent vs. 20 percent) pathways compared with low-risk patients.

The researchers found a difference in the biology of lung cancer between men and women. "In women, high-risk patients demonstrated increased activation of the invasiveness and STAT3 [a gene] pathways while high-risk men demonstrated increased activation of the STAT3, tumor necrosis factor, EGFR [epidermal growth factor receptor; a protein that plays a role in causing cells to grow and multiply], and wound healing pathways," the authors write.

"We believe our findings represent a novel approach to defining clinically relevant cohorts of NSCLC stratified by age and sex that are enriched for specific pathway activity and that would be more apt for therapeutic intervention when planning clinical trials with drugs that target specific pathway-related abnormalities or tumor biology. With genomic assays now being increasingly practical and clinically applicable, with turnaround times of 5 to 7 days, we believe our findings, while hypothesis generating and needing further validation, represent a step forward in defining pathway-driven cohorts of NSCLC that likely explain the age- and sex-specific differences seen in NSCLC," the authors conclude.


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. William Mostertz; Marvaretta Stevenson; Chaitanya Acharya; Isaac Chan; Kelli Walters; Wisut Lamlertthon; William Barry; Jeffrey Crawford; Joseph Nevins; Anil Potti. Age- and Sex-Specific Genomic Profiles in Non-Small Cell Lung Cancer. JAMA, 2010; 303 (6): 535-543 [link]

Cite This Page:

JAMA and Archives Journals. "Certain genetic profiles associated with recurrence-free survival for non-small cell lung cancer." ScienceDaily. ScienceDaily, 11 February 2010. <www.sciencedaily.com/releases/2010/02/100209182356.htm>.
JAMA and Archives Journals. (2010, February 11). Certain genetic profiles associated with recurrence-free survival for non-small cell lung cancer. ScienceDaily. Retrieved December 18, 2014 from www.sciencedaily.com/releases/2010/02/100209182356.htm
JAMA and Archives Journals. "Certain genetic profiles associated with recurrence-free survival for non-small cell lung cancer." ScienceDaily. www.sciencedaily.com/releases/2010/02/100209182356.htm (accessed December 18, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, December 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

UN: Up to One Million Facing Hunger in Ebola-Hit Countries

UN: Up to One Million Facing Hunger in Ebola-Hit Countries

AFP (Dec. 17, 2014) Border closures, quarantines and crop losses in West African nations battling the Ebola virus could lead to as many as one million people going hungry, UN food agencies said on Wednesday. Duration: 00:52 Video provided by AFP
Powered by NewsLook.com
When You Lose Weight, This Is Where The Fat Goes

When You Lose Weight, This Is Where The Fat Goes

Newsy (Dec. 17, 2014) Can fat disappear into thin air? New research finds that during weight loss, over 80 percent of a person's fat molecules escape through the lungs. Video provided by Newsy
Powered by NewsLook.com
Why Your Boss Should Let You Sleep In

Why Your Boss Should Let You Sleep In

Newsy (Dec. 17, 2014) According to research out of the University of Pennsylvania, waking up for work is the biggest factor that causes Americans to lose sleep. Video provided by Newsy
Powered by NewsLook.com
Flu Outbreak Closing Schools in Ohio

Flu Outbreak Closing Schools in Ohio

AP (Dec. 17, 2014) A wave of flu illnesses has forced some Ohio schools to shut down over the past week. State officials confirmed one pediatric flu-related death, a 15-year-old girl in southern Ohio. (Dec. 17) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins